Medical Device News Magazine

Timmy Garde Named Chief Growth Officer of Ardelis Health

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Ardelis Health, a healthcare strategic marketing agency and consulting firm partnering with innovators that discover, differentiate, and launch important therapies, today announced the appointment of industry veteran Timmy Garde as Chief Growth Officer.

“We are thrilled to welcome Timmy to the Ardelis leadership team. With his extensive industry experience and strategic perspective, he is the natural fit for this role,” said Jim Moran, co-founder and managing partner of Ardelis. “We are fortunate to work with innovative start-up and mid-stage biopharma companies that are developing vaccines and medicines for rare diseases, cancer, specialty therapeutic areas, and other patient needs, as well as partnering with diagnostic and medical device companies.”

Moran concluded, “We are committed to expanding our capabilities alongside them to support their efforts in advancing lifesaving solutions. Timmy will play a key role in evolving our services to meet the full business and marketing needs of our expanding client roster, and our new branding and website reflect these exciting changes to our team and offerings.”

Mr. Garde has more than 30 years’ experience in healthcare communication and business operations. In his most recent role, he served as Chief Innovation Leader at LevLane Advertising, where he drove breakthrough product launches and directed teams in U.S. Food and Drug Administration (FDA) approvals, compliance, marketing, and partnerships. Prior to that, Mr. Garde held the position of Chief Operating Officer at Calcium USA, where he was an early adopter of emerging digital healthcare trends and market impact, guiding new communications strategies for specialty pharma products, rare diseases, and more.

In addition to these roles, Mr. Garde is a force in the life sciences industry and a dedicated volunteer. He has launched and moderated annual Leaders in Life Sciences roundtable discussions and has mentored thousands of students at Penn State’s Smeal College of Business to support the next generation of marketing leaders. He was recently awarded the 2023 Smeal College of Business Service Award.

“I’m excited to join Ardelis and lead the next phase of our growth,” said Garde. “Our goal is to extend our marketing practice and provide unparalleled support to our clients’ executive and marketing teams by staying ahead of the curve and providing industry insights that can change the landscape. Together, we will help advance new medicines, diagnostics, medical devices, health technology, and digital healthcare products to make a powerful difference in the world and improve global health.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”